Committee for Advanced Therapies (CAT): 5-7 November 2025, European Medicines Agency, Amsterdam, the Netherlands, from 5 November 2025 to 7 November 2025

Committee for Advanced Therapies (CAT): 5-7 November 2025, European Medicines Agency, Amsterdam, the Netherlands, from 5 November 2025 to 7 November 2025

Standard operating procedure for processing of requests for fee reduction falling under paragraph 5 of Article 6 of Regulation (EU) 2024/568

Standard operating procedure for processing of requests for fee reduction falling under paragraph 5 of Article 6 of Regulation (EU) 2024/568

Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of authorisation: 28/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of authorisation: 28/02/2025, Revision: 1, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.